Today’s trading update highlights FY EBITDA in line with the Board’s expectations. The company’s aesthetics portfolio (representing 40% of sales in country operations and 60% of sales in international operations) remains the main driver of growth, with Silhouette in particular delivering a strong performance with sales of £8.7m (+120% like-for-like). A US launch of Silhouette Instalift is expected in early 2016. No results of the ongoing strategic review have been released.
